marty ross liposomal glutathione Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases: Heliyon Rhodiola rosea: a review in

Description

2006), lestaurtinib and becatecarin (Wishart et al

In summary, based on our review and the claims data analysis for cases in MS-DRGs 163, 164, and 165, and for MS-DRGs 166, 167, and 168 and cases reporting standard CDT or USAT with or without thrombolytic(s) and a principal diagnosis of PE, we believe that while this subset of cases for patients undergoing a thrombolysis (CDT or USAT) procedure for PE does not clinically align with patients undergoing surgery for malignancy or treatment for infection and does not involve the same level of complexity, monitoring or support as cases grouping to MS-DRGs 163, 164 and 165, the differences in resource consumption warrant proposed reassignment of these cases